New Procedure Spells Relief for Allergy Sufferers
Living in
While traditional allergy shots are given on a weekly basis over the span of a year or more, rush immunotherapy allows patients to receive the first six doses within a span of three hours, which minimizes overall treatment by months and delivers rapid results.
"With rush immunotherapy, we use the same science of traditional allergy shots but achieve results in one day,” said Summit Shah, M.D, of Premier Allergy. “Instead of having to wait months for your allergies or asthma to improve, you get results quicker and with fewer shots. Now patients with terrible allergies or uncontrolled asthma that couldn't make the commitment for weekly shots can get the treatment they deserve."
The concept behind allergy shots is similar to the flu vaccine—your immune system develops a resistance to the flu, or in the case of allergy shots, your immune system builds a tolerance for offending allergens such as ragweed, grass pollen or cat dander.
While allergy shot treatment is effective, it requires a significant time commitment. Until recently, this meant continued treatment for 3 to 5 years and symptoms were only relieved after hundreds of shots. Rush immunotherapy can show improvements within weeks with fewer visits for injections. Further, the treatment is fully covered by all major insurance companies.
“The best part about rush immunotherapy is that it's much more convenient," said
For more information on rush immunotherapy and other advanced treatment options for allergies, visit http://www.premierallergyohio.com.
Established by Dr. Summit Shah, graduate of the
For more information, contact:
(614) 328-9927
###
Read the full story at http://www.prweb.com/releases/2011/8/prweb8752439.htm


Chris Driver Selected for Leadership Columbia County
Advisor News
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
- DC plan sponsors see opportunity in alternatives
More Advisor NewsAnnuity News
- The next growth phase in life/annuities depends on modernization
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
- KBRA Assigns Rating to TruSpire Retirement Insurance Company
More Annuity NewsHealth/Employee Benefits News
- Findings from Yonsei University Advance Knowledge in Demography (Different Understandings of Scientific Research in the Use of De-identified Personal Sensitive Data: South Korea, in Comparative Perspectives): Science – Demography
- Data on Influenza Vaccines Discussed by Researchers at University of Lucerne (Keep Reminding Me To Get My Flu Shot): Immunization and Public Health – Influenza Vaccines
- Bobby Harrison: Rising insurance exchange costs bad for working poor
- New Managed Care Findings from Brown University Reported (Prior Authorization In Medicare Advantage: Beneficiary Exposure And Plan Disenrollment In 2021): Managed Care
- Findings on Managed Care Detailed by Researchers at Renal Research Institute (AI-Driven Interventions for Imminent Hospital Admissions in Patients with End-Stage Kidney Disease: A Medicare and EMR-Based Analysis): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on South Korea’s Non-Life Insurance Market
- Horace Mann Strengthens Customer Relationships and Accelerates Long-Term Growth Through Transactions with Medical Mutual of Ohio
- Regulators: ‘No firm conclusions’ from first offshore reinsurance filings
- Allianz Life Study Finds Americans Struggle to Shift From Retirement Saving to Spending
- The next growth phase in life/annuities depends on modernization
More Life Insurance News